Home/Filings/4/0001169245-20-000105
4//SEC Filing

Sharp John P 4

Accession 0001169245-20-000105

CIK 0001169245other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 6:43 PM ET

Size

4.9 KB

Accession

0001169245-20-000105

Insider Transaction Report

Form 4
Period: 2020-11-20
Sharp John P
CFO and Secretary
Transactions
  • Award

    Common Stock

    2020-11-20$3.00/sh+1,305$3,91541,305 total
Footnotes (1)
  • [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001342894

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:43 PM ET
Size
4.9 KB